Dementia News and Research

Latest Dementia News and Research

Caregivers selected to receive the 2013 Shire BRAVE Awards

Caregivers selected to receive the 2013 Shire BRAVE Awards

International researchers report significant findings on vascular abnormality outside the brain

International researchers report significant findings on vascular abnormality outside the brain

New diabetes has little impact on outcomes in elderly hypertensives

New diabetes has little impact on outcomes in elderly hypertensives

Research roundup: Meeting the needs of assisted living residents; Medicaid expansion and community health centers; money follows the person

Research roundup: Meeting the needs of assisted living residents; Medicaid expansion and community health centers; money follows the person

Study identifies possible link between orthostatic hypotension and atrial fibrillation

Study identifies possible link between orthostatic hypotension and atrial fibrillation

Non-specialist health workers provide treatment for people with MNS problems in developing countries

Non-specialist health workers provide treatment for people with MNS problems in developing countries

Viewpoints: Obamacare has resisted death throes before; website success stories from 3 governors; health law taking a toll on choice of doctors in Medicare Advantage

Viewpoints: Obamacare has resisted death throes before; website success stories from 3 governors; health law taking a toll on choice of doctors in Medicare Advantage

BIDMC pilot study shows promise for age-related cognitive disorders

BIDMC pilot study shows promise for age-related cognitive disorders

£20M research centre opened to investigate exciting new therapies for neurodegenerative diseases

£20M research centre opened to investigate exciting new therapies for neurodegenerative diseases

Research could refine next generation of drugs to help treat dementia

Research could refine next generation of drugs to help treat dementia

ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients

ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients

Novel IRL-1620 compound may be useful in treating Alzheimer's disease

Novel IRL-1620 compound may be useful in treating Alzheimer's disease

Single dose of intranasal insulin can help improve cognitive function in diabetes patients

Single dose of intranasal insulin can help improve cognitive function in diabetes patients

New center launched to increase efficacy, reduce costs at four health care providers across Indiana

New center launched to increase efficacy, reduce costs at four health care providers across Indiana

Researchers receive $7.5 million NIH grant to develop novel therapies for Alzheimer's disease

Researchers receive $7.5 million NIH grant to develop novel therapies for Alzheimer's disease

Researchers develop model that predicts earlier prediction of Alzheimer's disease in older adults

Researchers develop model that predicts earlier prediction of Alzheimer's disease in older adults

Arizona professor receives 2013 Rosalynn Carter Leadership in Caregiving Award

Arizona professor receives 2013 Rosalynn Carter Leadership in Caregiving Award

Drug used to treat intestinal worms could protect people from periodontitis, says study

Drug used to treat intestinal worms could protect people from periodontitis, says study

Researchers identify novel therapeutic approach for most frequent genetic cause of ALS

Researchers identify novel therapeutic approach for most frequent genetic cause of ALS

Scientists receive $1.2M grants to explore development of AD in individuals with Down syndrome

Scientists receive $1.2M grants to explore development of AD in individuals with Down syndrome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.